Mark H. Stoler

27.6k total citations · 7 hit papers
272 papers, 17.0k citations indexed

About

Mark H. Stoler is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Mark H. Stoler has authored 272 papers receiving a total of 17.0k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Epidemiology, 103 papers in Surgery and 56 papers in Oncology. Recurrent topics in Mark H. Stoler's work include Cervical Cancer and HPV Research (149 papers), Genital Health and Disease (61 papers) and Endometrial and Cervical Cancer Treatments (22 papers). Mark H. Stoler is often cited by papers focused on Cervical Cancer and HPV Research (149 papers), Genital Health and Disease (61 papers) and Endometrial and Cervical Cancer Treatments (22 papers). Mark H. Stoler collaborates with scholars based in United States, United Kingdom and Canada. Mark H. Stoler's co-authors include Philip E. Castle, Thomas C. Wright, Teresa L. Wright, Catherine Behrens, Thomas R. Broker, Diane Solomon, Mark Schiffman, Wim Quint, Lawrence Banks and Margaret Stanley and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Mark H. Stoler

267 papers receiving 16.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Biology and Life-Cycle of Human Papillomaviruses

2012 1.0k citations John Doorbar, Wim Quint et al. profile →
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

2012 1.0k citations Debbie Saslow, Diane Solomon et al. profile →
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

2012 745 citations Debbie Saslow, Diane Solomon et al. profile →
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

2011 650 citations Anna R. Giuliano, Mark H. Stoler et al. profile →
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

2012 613 citations Debbie Saslow, Diane Solomon et al. American Journal of Clinical Pathology profile →
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

2015 418 citations Mark H. Stoler et al. Gynecologic Oncology profile →
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

2011 391 citations Philip E. Castle, Mark H. Stoler et al. profile →

Peers

Countries citing papers authored by Mark H. Stoler

Since Specialization

Citations

This map shows the geographic impact of Mark H. Stoler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Stoler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Stoler more than expected).

Fields of papers citing papers by Mark H. Stoler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Stoler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Stoler. The network helps show where Mark H. Stoler may publish in the future.

Co-authorship network of co-authors of Mark H. Stoler

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Stoler. A scholar is included among the top collaborators of Mark H. Stoler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Stoler. Mark H. Stoler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transient receptor potential vanilloid 4 channel inhibition attenuates lung ischemia-reperfusion injury in a porcine lung transplant model 2024 ·Journal of Thoracic and Cardiovascular Surgery ·Raymond J. Strobel, Huy Q. Ta, (unknown), (unknown), (unknown), (unknown), Mark H. Stoler, Irving L. Kron, Swapnil K. Sonkusare, Mark E. Roeser, Victor E. Laubach	1
2	High prevalence of HPV16 and high‐grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2 2023 ·Acta Obstetricia Et Gynecologica Scandinavica ·(unknown), David Jenkins, Mark H. Stoler, Miekel M. van de Sandt, (unknown), Maurits N.C. de Koning, Wim Quint, Torben Steiniche, Lone Kjeld Petersen, Anne Hammer	10
3	Performance of HPV E4 and p16 ^INK4a biomarkers in predicting regression of cervical intraepithelial neoplasia grade 2 (CIN2): protocol for a historical cohort study 2022 ·BMJ Open ·(unknown), David Jenkins, (unknown), Wim Quint, Mark H. Stoler, John Doorbar, Johnny Kahlert, Patti E. Gravitt, Torben Steiniche, Lone Kjeld Petersen, Anne Hammer	5
4	Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial 2022 ·JNCI Journal of the National Cancer Institute ·Shangying Hu, Aimée R. Kreimer, Carolina Porras, Diego Guillén, Mario Alfaro, Teresa M. Darragh, Mark H. Stoler, (unknown), (unknown), Ana Cecilia Rodríguez, Mark Schiffman, Sabrina H. Tsang, Douglas R. Lowy, John T. Schiller, John Schussler, Wim Quint, Mitchell H. Gail, Joshua N. Sampson, Allan Hildesheim, Rolando Herrero, (unknown)	3
5	HER2 Overexpression and Amplification in Uterine Carcinosarcomas With Serous Morphology 2022 ·The American Journal of Surgical Pathology ·(unknown), Leigh A. Cantrell, Mark H. Stoler, Anne M. Mills	23
6	Vendor-specific microbiome controls both acute and chronic murine lung allograft rejection by altering CD4+Foxp3+ regulatory T cell levels 2019 ·American Journal of Transplantation ·Yizhan Guo, (unknown), Dongge Li, Oscar Okwudiri Onyema, (unknown), Amir Manafi, Anirban Banerjee, (unknown), Mark H. Stoler, Thomas H. Barker, David S. Wilkes, Andrew E. Gelman, Daniel Kreisel, (unknown)	25
7	Test Characteristics of Specific p16 Clones in the Detection of High-grade Squamous Intraepithelial Lesions (HSIL) 2017 ·International Journal of Gynecological Pathology ·(unknown), David C. Wilbur, Mark H. Stoler, Bradley J. Quade, Christina S. Kong	11
8	Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism 2017 ·Journal of Thoracic and Cardiovascular Surgery ·Eric J. Charles, J. Hunter Mehaffey, Ashish K. Sharma, Yunge Zhao, Mark H. Stoler, James M. Isbell, Christine L. Lau, Curtis G. Tribble, Victor E. Laubach, Irving L. Kron	35
9	Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study 2015 ·European Urology ·Staci L. Sudenga, Donna J. Ingles, Christine M. Pierce, Hui‐Yi Lin, William J. Fulp, Jane L. Messina, Mark H. Stoler, Martha Abrahamsen, Luisa L. Villa, Eduardo Lazcano‐Ponce, Anna R. Giuliano	53
10	Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death 2015 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Nicolas H. Pope, Eric J. Charles, (unknown), Ashish K. Sharma, Morgan Salmon, Benjamin T. Carter, Mark H. Stoler, Christine L. Lau, Victor E. Laubach, Irving L. Kron	43
11	An Evaluation of Novel, Lower-Cost Molecular Screening Tests for Human Papillomavirus in Rural China 2013 ·Cancer Prevention Research ·Fanghui Zhao, José Jerónimo, You‐Lin Qiao, Johannes Schweizer, Wen Chen, Melissa Valdez, Peter S. Lu, Xun Zhang, (unknown), Pooja Bansil, Proma Paul, (unknown), (unknown), Ping Bai, Roger Peck, Jing Li, Feng Chen, Mark H. Stoler, Philip E. Castle	88
12	American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer breakdown → 2012 ·American Journal of Clinical Pathology ·Debbie Saslow, Diane Solomon, Herschel W. Lawson, Maureen Killackey, Shalini Kulasingam, Joanna M. Cain, Francisco García, Ann Moriarty, Alan G. Waxman, David C. Wilbur, Nicolas Wentzensen, Levi S. Downs, Mark Spitzer, Anna-Barbara Moscicki, Eduardo L. Franco, Mark H. Stoler, Mark Schiffman, Philip E. Castle, Evan R. Myers	613
13	Cervical Stromal Invasion Predicting Survival in Endometrial Cancer 2010 ·Obstetrics and Gynecology ·J. Stuart Ferriss, William K. Brix, Rosemary Tambouret, Christopher P. DeSimone, Mark H. Stoler, Susan C. Modesitt	19
14	p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia 2002 ·The American Journal of Surgical Pathology ·Rüdiger Klaes, Axel Benner, (unknown), Rüdiger Ridder, C. Simon Herrington, David Jenkins, Robert J. Kurman, Dietmar Schmidt, Mark H. Stoler, Magnus von Knebel Doeberitz	354
15	Polymorphism at Codon 72 of p53 Is Not Associated with Cervical Cancer Risk 2000 ·Modern Pathology ·(unknown), Gwen Baber, James C. Boyd, Mark H. Stoler	25
16	Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. 1998 ·Journal of Clinical Investigation ·Richard I. Enelow, (unknown), Mark H. Stoler, (unknown), Jacob S. Young, Yang Lou, Thomas J. Braciale	94
17	The year book of pathology and laboratory medicine 1995 ·Mosby eBooks ·Stacey E. Mills, David E. Bruns, M. J. Gaffey, Mark H. Stoler	2
18	Human Papillomavirus Type 11 E1 up angle E4 and L1 Proteins Colocalize in the Mouse Xenograft System at Multiple Time Points 1995 ·Virology ·Darron R. Brown, Janine T. Bryan, Linda Pratt, (unknown), Kenneth H. Fife, Mark H. Stoler	21
19	Rapid dysplastic transformation of human genital cells by human papillomavirus type 18 1990 ·Gynecologic Oncology ·Willard A. Barnes, Craig D. Woodworth, Steven Waggoner, Mark H. Stoler, A. Bennett Jenson, Gregorio Delgado, Joseph A. DiPaolo	19
20	Distribution of disease at autopsy in 100 women with ovarian cancer 1988 ·Human Pathology ·Philip M. Dvoretsky, Keith Richards, Cynthia Angel, Linda G. Rabinowitz, Mark H. Stoler, Jackson B. Beecham, Thomas A. Bonfiglio	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact